Publicaciones en colaboración con investigadores/as de Hospital Universitario de Canarias (41)

2023

  1. Admixture mapping of severe asthma exacerbations in Hispanic/Latino children and youth

    Thorax, Vol. 78, Núm. 3, pp. 233-241

  2. Alpha-1 antitrypsin deficiency and Pi*S and Pi*Z SERPINA1 variants are associated with asthma exacerbations

    Pulmonology

  3. Bacterial Colonization of Microplastics at the Beaches of an Oceanic Island, Tenerife, Canary Islands

    International Journal of Environmental Research and Public Health, Vol. 20, Núm. 5

  4. Fluoride Levels in Supply Water from the Canary Islands Region

    Foods, Vol. 12, Núm. 4

  5. Human genetics influences microbiome composition involved in asthma exacerbations despite inhaled corticosteroid treatment

    Journal of Allergy and Clinical Immunology, Vol. 152, Núm. 3, pp. 799-806.e6

  6. The upper-airway microbiome as a biomarker of asthma exacerbations despite inhaled corticosteroid treatment

    Journal of Allergy and Clinical Immunology, Vol. 151, Núm. 3, pp. 706-715

2022

  1. Humoral response to SARS-CoV-2 after vaccination and booster effect in patients undergoing dialysis

    International Journal of Infectious Diseases, Vol. 122, pp. 327-331

  2. Multi-ancestry genome-wide association study of asthma exacerbations

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, Vol. 33, Núm. 6, pp. e13802

2021

  1. In vitro amoebicidal effects of arabinogalactan-based ophthalmic solution

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 16, pp. 9-16

2020

  1. In vitro evaluation of commercial foam Belcils® on Acanthamoeba spp

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 14, pp. 136-143

  2. Pharmacokinetics of Trastuzumab After Subcutaneous and Intravenous Administration in Obese Patients

    Annals of Pharmacotherapy, Vol. 54, Núm. 8, pp. 775-779

  3. The genomics and metagenomics of asthma severity (GEMAS) study: Rationale and design

    Journal of Personalized Medicine, Vol. 10, Núm. 3, pp. 1-16

2019

  1. In vitro evaluation of combined commercialized ophthalmic solutions against acanthamoeba strains

    Pathogens, Vol. 8, Núm. 3

2018

  1. Fatty acid composition and eicosanoid levels (LTE 4 and PGE 2 ) of human milk from normal weight and overweight mothers

    Breastfeeding Medicine, Vol. 13, Núm. 10, pp. 702-710

  2. Effect of UGT, SLCO, ABCB and ABCC polymorphisms on irinotecan toxicity

    Medicina Clinica, Vol. 151, Núm. 11, pp. 425-430

  3. Presence of Acanthamoeba in the ocular surface in a Spanish population of contact lens wearers

    Acta Parasitologica, Vol. 63, Núm. 2, pp. 393-396

  4. Toxic effects of selected proprietary dry eye drops on Acanthamoeba

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. 5-fluorouracil toxicity in the treatment of colon cancer associated with the genetic polymorphism 2846 A>G (rs67376798)

    Journal of Oncology Pharmacy Practice, Vol. 23, Núm. 5, pp. 396-398

  2. Evaluation of the anti-Acanthamoeba activity of two commercial eye drops commonly used to lower eye pressure

    Experimental Parasitology, Vol. 183, pp. 117-123

  3. Influence of Anthropometric Characteristics in Patients With Her2-Positive Breast Cancer on Initial Plasma Concentrations of Trastuzumab

    Annals of Pharmacotherapy, Vol. 51, Núm. 11, pp. 976-980